PROCEEDINGS OF A NATIONAL-CANCER-INSTITUTE WORKSHOP - PET IN ONCOLOGY - A CLINICAL RESEARCH AGENDA

被引：32

作者：

WAHL, RL

HAWKINS, RA

LARSON, SM

HENDEE, WR

COLEMAN, RE

HOLDEN, RW

FRICK, MP

GATSONIS, C

BROWN, GS

SHTERN, F

机构：

[1] UNIV CALIF LOS ANGELES,DIV NUCL MED,LOS ANGELES,CA

[2] CORNELL UNIV,SCH MED,DEPT RADIOL,NEW YORK,NY

[3] MEM SLOAN KETTERING CANC CTR,DIV NUCL MED,NEW YORK,NY

[4] MED COLL WISCONSIN,MILWAUKEE,WI

[5] DUKE UNIV,SCH MED,DEPT RADIOL,DIV NUCL MED,DURHAM,NC

[6] INDIANA UNIV,SCH MED,DEPT RADIOL,INDIANAPOLIS,IN

[7] CREIGHTON UNIV,SCH MED,DEPT RADIOL,OMAHA,NE

[8] HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA

[9] NCI,RADIAT RES PROGRAM,ROCKVILLE,MD

[10] NCI,DIAGNOST IMAGING RES BRANCH,ROCKVILLE,MD

来源：

RADIOLOGY | 1994年 / 193卷 / 03期

关键词：

EDITORIALS; EMISSION CT (ECT); NEOPLASMS;

D O I：

10.1148/radiology.193.3.7972793

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

On November 28, 1992, the National Cancer Institute sponsored a workshop to discuss the current state of positron emission tomography (PET) applications in clinical oncology and to identify areas of consensus regarding a targeted research agenda in this growing field. Workshop members concluded that PET with the use of the glucose analog 18-F-fluoro-2-deoxy-D-glucose (FDG) has demonstrated substantial clinical potential as a method to (a) depict and characterize masses, (b) depict regional metastatic disease involving lymph nodes, (c) depict systemic metastases of cancer, and (d) help assess the response of cancers to a variety of therapies. More broad-based research directed at advancing our ability to apply the PET method to cancer diagnosis and treatment monitoring is needed. There was also a consensus that rigorous prospective trials of the PET method should be performed with current technology, transverse attenuation-corrected PET scans to determine the accuracy of PET in the characterization and regional staging of primary lung and breast cancers. Rational application of the PET method to cancer management will be accomplished better after the results of these research studies become available.

引用

页码：604 / 606

页数：3

共 28 条

[11]

HAWKINS RA, 1992, J NUCL MED, V33, P633

[12]

KERN KA, 1988, J NUCL MED, V29, P181

[13]

KUBOTA K, 1985, J NUCL MED, V26, P37

[14]

KUBOTA K, 1989, J COMPUT ASSIST TOMO, V13, P1097

[15]

NOLOP KB, 1987, CANCER, V60, P2682, DOI 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO

[16]

2-H

[17]

OKADA J, 1991, J NUCL MED, V32, P686

[18]

OKAZUMI S, 1992, J NUCL MED, V33, P333

[19] SERIAL FDG-PET STUDIES IN THE PREDICTION OF SURVIVAL IN PATIENTS WITH PRIMARY BRAIN-TUMORS [J].

SCHIFTER, T ;

HOFFMAN, JM ;

HANSON, MW ;

BOYKO, OB ;

BEAM, C ;

PAINE, S ;

SCHOLD, SC ;

BURGER, PC ;

COLEMAN, RE .

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1993, 17 (04) :509-516

[20] RECURRENCE OF COLORECTAL TUMORS - PET EVALUATION [J].

STRAUSS, LG ;

CLORIUS, JH ;

SCHLAG, P ;

LEHNER, B ;

KIMMIG, B ;

ENGENHART, R ;

MARINGREZ, M ;

HELUS, F ;

OBERDORFER, F ;

SCHMIDLIN, P ;

VANKAICK, G .

RADIOLOGY, 1989, 170 (02) :329-332

← 1 2 3 →